{"id":11889,"date":"2013-10-30T09:58:08","date_gmt":"2013-10-30T13:58:08","guid":{"rendered":"https:\/\/cablemanpro.com\/wallstreetpr\/?p=11889"},"modified":"2013-10-30T09:57:07","modified_gmt":"2013-10-30T13:57:07","slug":"merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results","status":"publish","type":"post","link":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889","title":{"rendered":"Merck &#038; Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results"},"content":{"rendered":"<p style=\"text-align: justify;\">Boston, MA 10\/30\/2013 (wallstreetpr) &#8211;<b>\u00a0<\/b>Merck &amp; Co., Inc. (NYSE:MRK) shares take a tumble following the poor weak earnings the company posted for the third quarter of 2013. The company continues to be troubled by patent issues with key drugs, which was further complicated by currency flip-flops. Both of the above primary drivers for the company were further compounded by fall in sale of diabetes drug in the US.<\/p>\n<p style=\"text-align: justify;\">Merck has lost much of its sheen as a premier research and development drug maker, since a distinct decline in the overall productivity in this division has been noticeable. Besides, Merck is concerned with developing drugs focused on major diseases and this has proved to be contrary for the company.<\/p>\n<p style=\"text-align: justify;\">The shift in focus in Research and Development for most of the modern pharma companies has led to Merck\u2019s slow-down. Working on various verticals these companies address needs of niche pharma sectors offering unique, innovative products focusing on genetics-based solutions.<\/p>\n<p style=\"text-align: justify;\">Merck is expected to move towards more innovative research and development soon \u2013 with likely focus on cancer, and immunology segments. Most other companies are already expanding into this segment as there are several subsections of diseases in this segment that allow for product innovation and development of niche pharma solutions.<\/p>\n<p style=\"text-align: justify;\">The major drawback for Merck in the recent past has been the failure of its diabetes-niche drugs \u2013 Januvia and Janumet- in the U.S. markets. These drugs are found to be very effective in treating Diabetes Type 2. Worldwide both the drugs have seen good sales. However, in the U.S. alone the sale of these two drugs has fallen by nearly 8%.<\/p>\n<p style=\"text-align: justify;\">The decline in the sale of these two drugs has been attributed to the sale of &#8211; Invokana- a drug launched by Johnson &amp; Johnson in the first quarter of this year. Invokana has lowered the sales of Januvia in particular.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Boston, MA 10\/30\/2013 (wallstreetpr) &#8211;\u00a0Merck &amp; Co., Inc. (NYSE:MRK) shares take a tumble following the poor weak earnings the company posted for the third quarter [&hellip;]<\/p>\n","protected":false},"author":13,"featured_media":11896,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"rop_custom_images_group":[],"rop_custom_messages_group":[],"rop_publish_now":"initial","rop_publish_now_accounts":{"twitter_2902945987_2902945987":""},"rop_publish_now_history":[],"rop_publish_now_status":"pending","footnotes":""},"categories":[264],"tags":[1683,3273,1126,1123],"stock_ticker":[],"class_list":["post-11889","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-health","tag-merck-co-inc-nysemrk","tag-merck-co-inc","tag-mrk","tag-nysemrk","entry"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v26.9 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Merck &amp; Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results - Wall Street PR<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Merck &amp; Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results - Wall Street PR\" \/>\n<meta property=\"og:description\" content=\"Boston, MA 10\/30\/2013 (wallstreetpr) &#8211;\u00a0Merck &amp; Co., Inc. (NYSE:MRK) shares take a tumble following the poor weak earnings the company posted for the third quarter [&hellip;]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889\" \/>\n<meta property=\"og:site_name\" content=\"Wall Street PR\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/WallStreetPR\/\" \/>\n<meta property=\"article:published_time\" content=\"2013-10-30T13:58:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"768\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/jpeg\" \/>\n<meta name=\"author\" content=\"Lisa Ray\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Lisa Ray\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"2 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#article\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889\"},\"author\":{\"name\":\"Lisa Ray\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\"},\"headline\":\"Merck &#038; Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results\",\"datePublished\":\"2013-10-30T13:58:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889\"},\"wordCount\":324,\"commentCount\":0,\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg\",\"keywords\":[\"Merck &amp; Co Inc. (NYSE:MRK)\",\"Merck &amp; Co. Inc.\",\"MRK\",\"NYSE:MRK\"],\"articleSection\":[\"Health\"],\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889\",\"name\":\"Merck & Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results - Wall Street PR\",\"isPartOf\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#primaryimage\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#primaryimage\"},\"thumbnailUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg\",\"datePublished\":\"2013-10-30T13:58:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#primaryimage\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg\",\"width\":1024,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Merck &#038; Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#website\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"name\":\"Wall Street PR\",\"description\":\"Latest News From WallStreet\",\"publisher\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#organization\",\"name\":\"Wall Street PR\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png\",\"width\":537,\"height\":70,\"caption\":\"Wall Street PR\"},\"image\":{\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/\"},\"sameAs\":[\"https:\/\/www.facebook.com\/WallStreetPR\/\",\"https:\/\/x.com\/WallstreetPRs\"]},{\"@type\":\"Person\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c\",\"name\":\"Lisa Ray\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"contentUrl\":\"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png\",\"caption\":\"Lisa Ray\"},\"description\":\"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.\",\"sameAs\":[\"https:\/\/cablemanpro.com\/wallstreetpr\"],\"url\":\"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Merck & Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results - Wall Street PR","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889","og_locale":"en_US","og_type":"article","og_title":"Merck & Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results - Wall Street PR","og_description":"Boston, MA 10\/30\/2013 (wallstreetpr) &#8211;\u00a0Merck &amp; Co., Inc. (NYSE:MRK) shares take a tumble following the poor weak earnings the company posted for the third quarter [&hellip;]","og_url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889","og_site_name":"Wall Street PR","article_publisher":"https:\/\/www.facebook.com\/WallStreetPR\/","article_published_time":"2013-10-30T13:58:08+00:00","og_image":[{"width":1024,"height":768,"url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg","type":"image\/jpeg"}],"author":"Lisa Ray","twitter_misc":{"Written by":"Lisa Ray","Est. reading time":"2 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#article","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889"},"author":{"name":"Lisa Ray","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c"},"headline":"Merck &#038; Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results","datePublished":"2013-10-30T13:58:08+00:00","mainEntityOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889"},"wordCount":324,"commentCount":0,"publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg","keywords":["Merck &amp; Co Inc. (NYSE:MRK)","Merck &amp; Co. Inc.","MRK","NYSE:MRK"],"articleSection":["Health"],"inLanguage":"en-US","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#respond"]}]},{"@type":"WebPage","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889","url":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889","name":"Merck & Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results - Wall Street PR","isPartOf":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website"},"primaryImageOfPage":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#primaryimage"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#primaryimage"},"thumbnailUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg","datePublished":"2013-10-30T13:58:08+00:00","breadcrumb":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#primaryimage","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2013\/10\/2311.jpg","width":1024,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/merck-co-inc-nysemrk-falters-over-januvia-sales-and-poor-q3-results-11889#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/cablemanpro.com\/wallstreetpr\/"},{"@type":"ListItem","position":2,"name":"Merck &#038; Co., Inc. (NYSE:MRK) Falters Over Januvia Sales And Poor Q3 Results"}]},{"@type":"WebSite","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#website","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","name":"Wall Street PR","description":"Latest News From WallStreet","publisher":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/cablemanpro.com\/wallstreetpr\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#organization","name":"Wall Street PR","url":"https:\/\/cablemanpro.com\/wallstreetpr\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/10\/brand-logo.png","width":537,"height":70,"caption":"Wall Street PR"},"image":{"@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/WallStreetPR\/","https:\/\/x.com\/WallstreetPRs"]},{"@type":"Person","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/c58aa72f5e3994c817e3654937496b1c","name":"Lisa Ray","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/cablemanpro.com\/wallstreetpr\/#\/schema\/person\/image\/","url":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","contentUrl":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-content\/uploads\/2019\/06\/2b2b9819092dcc9a125cbbf7b3645b09.png","caption":"Lisa Ray"},"description":"Lisa has a Bachelor of Arts in journalism from Purdue University and 3 years of experience in the publishing field.","sameAs":["https:\/\/cablemanpro.com\/wallstreetpr"],"url":"https:\/\/cablemanpro.com\/wallstreetpr\/author\/linsay-thomas"}]}},"_links":{"self":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/11889","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/users\/13"}],"replies":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/comments?post=11889"}],"version-history":[{"count":0,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/posts\/11889\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media\/11896"}],"wp:attachment":[{"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/media?parent=11889"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/categories?post=11889"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/tags?post=11889"},{"taxonomy":"stock_ticker","embeddable":true,"href":"https:\/\/cablemanpro.com\/wallstreetpr\/wp-json\/wp\/v2\/stock_ticker?post=11889"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}